Michael Bonney - Tekla Life Insider

XHQLX -- USA Fund  

USD 20.98  0.03  0.14%

Mr. Michael W. Bonney is Independent Trustee of HQ Life Sciences Investors., since 2011. Mr. Bonney is the Chief Executive Officer and member of the Board of Directors of Cubist Pharmaceuticals, Inc. until December, 2014, providing each Fund with valuable insight into operating matters relating to biotech companies and the overall healthcare industry. He serves on the Valuation Committee and is Chairman of the Governance and Nominating Committee of each Fund
Age: 58  Executive Since 2011      
Bonney is also a Director of Alnylam Pharmaceuticals, Inc. and is Chairman of the Board of Trustees of Bates College. He holds a BA degree from Bates College.

Michael Bonney Latest Insider Activity

Management Performance (%)

Similar Money Managers

Found 11 records

One Year Return

Carl EichstaedtWestern Asset Core Plus Bond I
Dina PerryAmerican Funds Fundamental Invs
Barbara MillerJPMorgan Core Bond I
Andrew OBrienLord Abbett Short Duration Inco
Barbara MillerJPMorgan Core Bond R4
Bob MillerBlackRock Strategic Income Opps
James LovelaceAmerican Funds Capital Income B
Carl EichstaedtWestern Asset Core Plus Bond FI
Mark DenningAmerican Funds SMALLCAP World R
Rick RiederBlackRock Strategic Income Opps
Daniel ShackelfordT Rowe Price New Income R

Fund Summary

The fund is listed under null category and is part of null family.

Tekla Life Sciences Leadership Team

William Reardon, Independent Trustee
Michael Bonney, Independent Trustee
Oleg Pohotsky, Independent Trustee
Lucinda Stebbins, Independent Trustee
Daniel Omstead, President Trustee
Uwe Reinhardt, Independent Trustee
Rakesh Jain, Independent Trustee

Fund Performance Indicators

Current Sentiment - XHQLX

Tekla Life Sciences Investor Sentiment
Macroaxis portfolio users are unemotional in their outlook on investing in Tekla Life Sciences Investors. What is your outlook on investing in Tekla Life Sciences Investors? Are you bullish or bearish?
50% Bullish
50% Bearish

Also Currentnly Active

Purchased over 20 shares of
few hours ago
Traded for 106.27
Purchased over 200 shares of
few hours ago
Traded for 10.56
Purchased over 70 shares of
few hours ago
Traded for 39.4
See also Your Current Watchlist. Please also try CEO Directory module to screen ceos from public companies around the world.